NCT06624644 2025-09-10A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory MelanomaLinnaeus Therapeutics, Inc.Phase 2/3 Recruiting135 enrolled
NCT02327078 2025-08-14A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204)Incyte CorporationPhase 1/2 Completed307 enrolled 27 charts
NCT03329950 2024-03-28A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced MalignanciesCelldex TherapeuticsPhase 1 Completed132 enrolled
NCT01245062 2018-04-05GSK1120212 vs Chemotherapy in Advanced or Metastatic BRAF V600E/K Mutation-positive MelanomaGlaxoSmithKlinePhase 3 Completed322 enrolled 24 charts
NCT01709162 2015-11-30Study to Compare the Effect of Ipilimumab Retreatment With That of Chemotherapy in Advanced MelanomaBristol-Myers SquibbPhase 2 Terminated31 enrolled 11 charts
NCT00041808 2005-06-24Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the LiverFeRxPhase 1/2 Completed20 enrolled